ALUR
Allurion·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 4
Stock Price Surged Significantly
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
Price Hits New Low
Price Hits 52-week Low
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ALUR
Allurion Technologies, Inc.
A first-class obesity body management platform
Healthcare Equipment and Supplies
--
03/29/2021
New York Stock Exchange
134
12-31
Common stock
11 Huron Drive, Natick, MA 01760
--
Allurion Technologies, Inc., as a Delaware corporation. The company is committed to ending obesity by creating a best-in-class weight loss platform to treat the estimated 2 billion overweight people worldwide. The company's platform, Allurion Program, utilizes the world's first and only swallowable, programless intragastric weight loss balloon and offers the opportunity to use AI-powered remote patient monitoring tools, proprietary behavior modification programs, secure messaging and video telemedicine, all provided by the company.
Earnings Call
Company Financials
EPS
ALUR has released its 2025 Q3 earnings. EPS was reported at -1.53, versus the expected -2.45, beating expectations. The chart below visualizes how ALUR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ALUR has released its 2025 Q3 earnings report, with revenue of 2.66M, reflecting a YoY change of -50.48%, and net profit of -11.88M, showing a YoY change of -236.03%. The Sankey diagram below clearly presents ALUR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



